Ma L - Search Results

1

Role of NKG2D in cytokine-induced killer cells against multiple myeloma cells.

Lu X, Zhu A, Cai X, Jia Z, Han W, Ma L, Zhou M, Qian K, Cen L, Chen B. Lu X, et al. Among authors: ma l. Cancer Biol Ther. 2012 Jun;13(8):623-9. doi: 10.4161/cbt.19850. Epub 2012 Jun 1. Cancer Biol Ther. 2012. PMID: 22555808 Free article.

2

STAT3 contributes to NK cell recognition by modulating expression of NKG2D ligands in adriamycin-resistant K562/AO2 cells.

Cai X, Lu X, Jia Z, Zhang X, Han W, Rong X, Ma L, Zhou M, Chen B. Cai X, et al. Among authors: ma l. Int J Hematol. 2015 Nov;102(5):536-43. doi: 10.1007/s12185-015-1860-7. Epub 2015 Sep 19. Int J Hematol. 2015. PMID: 26387089

3

[Roles of NKG2D in cytokine-induced killer (CIK) against hematological malignant cells lines].

He JY, Jia ZX, Cai XH, Han WM, Xiao R, Ma LD, Lu XZ, Zhou M, Chen BA. He JY, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Dec;21(6):1380-4. doi: 10.7534/j.issn.1009-2137.2013.06.003. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 24370015 Chinese.

4

[Effects of matrine on the expression of NKG2D ligands in leukemia cells].

Ma LD, Lu XZ, Zhu ZC, Jiang LJ, Zhou M, Qian SX, Li JY. Ma LD, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Dec;21(6):1429-34. doi: 10.7534/j.issn.1009-2137.2013.06.012. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 24370024 Chinese.

5

[NKG2D-mediated natural killer cell cytotoxicity against myeloid leukemia cells OUN-1].

Lu XZ, Cai XH, Ma LD, Chen BA. Lu XZ, et al. Zhonghua Xue Ye Xue Za Zhi. 2012 Jun;33(6):444-7. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22967377 Chinese.

6

Matrine increases NKG2D ligand ULBP2 in K562 cells via inhibiting JAK/STAT3 pathway: a potential mechanism underlying the immunotherapy of matrine in leukemia.

Lu X, Zhu Z, Jiang L, Sun X, Jia Z, Qian S, Li J, Ma L. Lu X, et al. Among authors: ma l. Am J Transl Res. 2015 Oct 15;7(10):1838-49. eCollection 2015. Am J Transl Res. 2015. PMID: 26692928 Free PMC article.

7

[Up-regulation of NKG2D ligand ULBP2 by matrine in K562 cells and the underlying molecular mechanisms].

Ma L, Zhu Z, Lu X, Jiang L, Zhou M, Qian S, Li J. Ma L, et al. Zhonghua Xue Ye Xue Za Zhi. 2014 May;35(5):438-42. doi: 10.3760/cma.j.issn.0253-2727.2014.05.013. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24857216 Chinese.

8

[Enhanced cytotoxicity against leukemia cells of natural Killer cells from cord blood after expansion in vitro].

Zhou F, Han WM, Jia ZX, Yang JH, Xiao R, Ma LD, Lu XZ. Zhou F, et al. Zhonghua Xue Ye Xue Za Zhi. 2013 Nov;34(11):952-6. doi: 10.3760/cma.j.issn.0253-2727.2013.11.009. Zhonghua Xue Ye Xue Za Zhi. 2013. Retraction in: Zhonghua Xue Ye Xue Za Zhi. 2014 Jan;35(1):76. doi: 10.3760/cma.j.issn.0253-2727.2014.01.023 PMID: 24294851 Retracted. Chinese.

9

Matrine suppresses cell growth of human chronic myeloid leukemia cells via its inhibition of the interleukin-6/Janus activated kinase/signal transducer and activator of transcription 3 signaling cohort.

Ma L, Zhu Z, Jiang L, Sun X, Lu X, Zhou M, Qian S, Jianyong L. Ma L, et al. Leuk Lymphoma. 2015;56(10):2923-30. doi: 10.3109/10428194.2015.1007507. Epub 2015 Mar 11. Leuk Lymphoma. 2015. PMID: 25629992

10

STAT3 signaling pathway is involved in decitabine induced biological phenotype regulation of acute myeloid leukemia cells.

Zhu Z, Lu X, Jiang L, Sun X, Zhou H, Jia Z, Zhang X, Ma L. Zhu Z, et al. Among authors: ma l. Am J Transl Res. 2015 Oct 15;7(10):1896-907. eCollection 2015. Am J Transl Res. 2015. PMID: 26692933 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,475 results

Search Page

Filters